Abstract:OBJECTIVE:Cellular proliferate inhibition, senescence or apoptosis are induced by telomere shortening through the activation of P53 pathway, but so far, little is known of the mechanism. This study aimed to clarify the molecular regulation of P53 through telomere pathway by the investigation of molecular interaction between P53 and the main telomere associated protein telomeric repeat binding protein 1(TRBP1) in vitro.METHODS:Glutathione S-transferase (GST) alone and 4 different human P53-GST fusion proteins were expressed in E.coli. and purified through glutathione Sepharose (TM)4B by affinity chromatography, P53s were wild type P53 (1-393), N terminal truncated form P53 2C (95-393), C terminal truncated form P53 N5 (2-293) and single amino acid mutant P53 R175H (175 arginine to histidine). Glutathione Sepharose (TM)4B, purified GST alone and P53 fusions were mixed with human breast cancer cell line MCF-7 cellular protein extracts through in vitro binding assay-pull down, the molecular interaction between P53 and TRBP1 were detected by Western blot.RESULTS:SDS-PAGE and Coomassie brilliant blue staining showed that the molecular weights of all the purified proteins were as expected and purities were over 90%. Western blot of TRBP1 showed that both wild type P53 and P53 R175H could bind to TRBP1 of MCF-7 cells, and their binding capacities are similar, whereas GST alone and Glutathione Sepharose(TM) 4B beads could not. Compared with both of them, the interaction between P53 2C and TRBP1 enhanced dramatically, but between P53 N5 and TRBP1 reduced significantly.CONCLUSION:P53 can interact with TRBP1 directly and in vitro, C terminus of P53 (293-393) is the structural domain of their interaction. This C terminus domain dependent interaction between P53 and TRBP1 may be related to the cellular activities induced by telomere dynamic changing.

Expression, purification, and in vitro mitochondrial interaction analysis of full-length and truncated human tumor suppresser p53

Global Investigation of p53-induced Apoptosis Through Quantitative Proteomic Profiling Using Comparative Amino Acid-coded Tagging

P53:Pro-Death Factor That Directly Targets Mitochondria for Triggering Apoptosis

Tumor Suppressor P53 Restrains Cancer Cell Dissemination by Modulating Mitochondrial Dynamics

Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies

Expression,purification and Transduction of PTD-p53 Fusion Protein to Hepatocellular Carcinoma Cell

The ARTS of p53-dependent mitochondrial apoptosis

P53 regulates mitochondrial biogenesis via transcriptionally induction of mitochondrial ribosomal protein L12

Expression of p53-TAT fusion protein and its apoptosis-inducing activity on HepG 2 cells

The Development of P53-Targeted Therapies for Human Cancers

Induction of P53 Expression and Apoptosis by a Recombinant Dual-Target MDM2/MDMX Inhibitory Protein in Wild-Type P53 Breast Cancer Cells.

Interaction of Tumor Suppressor P53 with DNA and Proteins.

Mitochondrial Uncoupling Inhibits P53 Mitochondrial Translocation in TPA-Challenged Skin Epidermal JB6 Cells

[The Molecular Interaction Between P53 and Telomeric Repeat Binding Protein 1 in Vitro].

Post-translational regulation of p53 function through 20S proteasome-mediated cleavage

p53 protein abundance is a therapeutic window across TP53 mutant cancers and is targetable with proximity inducing small molecules

The relationship between p53 and mitochondrial

Network effect of Wt-mutant p53 interactions and implications on p53 gene therapy.

Resuscitating the Guardian: Current Progress in P53-Based Anti-Tumor Therapy

A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins

P53 and Its Downstream Proteins As Molecular Targets of Cancer